كندا - الإنجليزية - Health Canada

biologische heilmittel heel gmbh - papaverine; papaverine; papaverine - liquid - 12d; 30d; 200d - papaverine 12d; papaverine 30d; papaverine 200d - homeopathic products

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - atracurium besilate, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections; benzenesulfonic acid - tracrium is a highly selective, competitive or non-depolarising neuromuscular blocking agent which is used as an adjunct to general anaesthesia to enable tracheal intubation to be performed and to relax skeletal muscles during surgery or controlled ventilation, and to facilitate mechanical ventilation in intensive care unit (icu) patients.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - atracurium besilate, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - tracrium is a highly selective, competitive or non-depolarising neuromuscular blocking agent which is used as an adjunct to general anaesthesia to enable tracheal intubation to be performed and to relax skeletal muscles during surgery or controlled ventilation, and to facilitate mechanical ventilation in intensive care unit (icu) patients.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - papaverine hydrochloride -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

stada pharmaceuticals australia pty ltd - apomorphine hydrochloride hemihydrate, quantity: 50 mg - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium hydroxide; hydrochloric acid - movapo is indicated to reduce the number and severity of "off" phases in patients with parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with movapo should be undertaken by a specialist unit in a hospital setting. conventional therapy should be continued during "on" phases.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

stada pharmaceuticals australia pty ltd - apomorphine hydrochloride hemihydrate, quantity: 20 mg - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium hydroxide; hydrochloric acid - movapo is indicated to reduce the number and severity of "off" phases in patients with parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with movapo should be undertaken by a specialist unit in a hospital setting. conventional therapy should be continued during "on" phases.

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

bracco uk ltd - iopamidol - solution for injection - 340mg/1ml

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

bracco uk ltd - iopamidol - solution for injection - 340mg/1ml

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

bracco uk ltd - iopamidol - solution for injection - 340mg/1ml

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

bracco uk ltd - iopamidol - solution for injection - 340mg/1ml